Literature DB >> 12532494

Microbiological study of neonatal conjunctivitis with special reference to Chlamydia trachomatis.

Mukula Mohile1, Ashok K Deorari, Gita Satpathy, Anjana Sharma, Meharban Singh.   

Abstract

PURPOSE: To study the microbial agents, chiefly Chlamydia trachomatis and other bacteria, in neonatal conjunctivitis.
METHODS: Conjunctival specimens from 70 newborns with conjunctivitis were subjected to bacterial culture and sensitivity testing, monoclonal antibody based C. trachomatis antigen detection test and species-specific Chlamydia antibody detection in the sera of babies and their mothers, by micro-immunofluorescence assay.
RESULTS: Bacteria were isolated from 35 (50%) babies; the majority (20, 57.14%) were Staphylococcus epidermidis. C. trachomatis antigen was detected in conjunctival smears of 17 (24%) babies, and 6 (35.29%) of them were positive for other bacteria. Six babies and their mothers tested positive for C. trachomatis Ig G antibodies. At follow-up after 14 weeks, 6 (35.29%) of the Chlamydia antigen-positive babies were found to have developed recurrent conjunctivitis.
CONCLUSION: C. trachomatis is responsible for almost a quarter of all cases of neonatal conjunctivitis, with recurrences in 35% of cases. Bacteria could be isolated from 50% of the patients though the exact role of Staphylococcus epidermidis, isolated from 28.65% of the neonatal conjunctivitis cases, remains unclear.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12532494

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  13 in total

Review 1.  Management of Extraocular Infections.

Authors:  Srinivasan Muthiah; Naveen Radhakrishnan
Journal:  Indian J Pediatr       Date:  2017-07-14       Impact factor: 1.967

2.  Burden of acute infections (except respiratory and diarrheal) and its risk factors among under-five children in India: A systematic review and meta-analysis.

Authors:  Enakshi Ganguly; Pawan K Sharma; Clareann H Bunker
Journal:  Indian J Child Health (Bhopal)       Date:  2016-03-15

3.  Risk factors for neonatal conjunctivitis in babies of HIV-1 infected mothers.

Authors:  Stephen Gichuhi; Rose Bosire; Dorothy Mbori-Ngacha; Christine Gichuhi; Dalton Wamalwa; Elizabeth Maleche-Obimbo; Carey Farquhar; Grace Wariua; Phelgona Otieno; Grace C John-Stewart
Journal:  Ophthalmic Epidemiol       Date:  2009 Nov-Dec       Impact factor: 1.648

Review 4.  Neonatal chlamydial infections: prevention and treatment.

Authors:  Heather J Zar
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 5.  Neonatal conjunctivitis - a review.

Authors:  Ps Mallika; T Asok; Ha Faisal; S Aziz; Ak Tan; G Intan
Journal:  Malays Fam Physician       Date:  2008-08-31

6.  Interventions for preventing ophthalmia neonatorum.

Authors:  Vimal Scott Kapoor; Jennifer R Evans; S Swaroop Vedula
Journal:  Cochrane Database Syst Rev       Date:  2020-09-21

7.  Ophthalmia neonatorum treatment and prophylaxis: IPOSC global study.

Authors:  Ofira Zloto; Almutez Gharaibeh; Eedy Mezer; Branislav Stankovic; Sherwin Isenberg; Tamara Wygnanski-Jaffe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-26       Impact factor: 3.117

8.  A study of Ophthalmia Neonatorum in the Central Reion of Ghana: Causative Agents and Antibiotic Susceptibility Patterns.

Authors:  Samuel Bert Boadi-Kusi; Samuel Kyei; Selina Holdbrook; Emmanuel Kwasi Abu; Jonathan Ntow; Abena Mantebea Ateko
Journal:  Glob Pediatr Health       Date:  2021-05-28

9.  Pathogenic bacteria and their antibiotic sensitivity in ophthalmia neonatorum.

Authors:  Prabhakar Suhas; S Vishnu; M Muthayya
Journal:  Oman J Ophthalmol       Date:  2021-06-28

10.  Ocular Chlamydia trachomatis infections in patients attending a tertiary eye care hospital in north India: a twelve year study.

Authors:  Anjana Sharma; Gita Satpathy; Niranjan Nayak; Radhika Tandon; Namrata Sharma; Jeewan Singh Titiyal; Anita Panda; Rasik Behari Vajpayee; Ravinder Mohan Pandey
Journal:  Indian J Med Res       Date:  2012-12       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.